Globe Life (NYSE:GL - Get Free Report) will likely be announcing its Q3 2025 results after the market closes on Wednesday, October 22nd. Analysts expect the company to announce earnings of $4.52 per share and revenue of $1.5192 billion for the quarter. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS.Investors may visit the the company's upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Thursday, October 23, 2025 at 11:00 AM ET.
Globe Life (NYSE:GL - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The company reported $3.27 EPS for the quarter, topping analysts' consensus estimates of $3.25 by $0.02. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. The business had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.50 billion. During the same period last year, the business posted $2.97 earnings per share. The firm's quarterly revenue was up 2.9% on a year-over-year basis. On average, analysts expect Globe Life to post $14 EPS for the current fiscal year and $15 EPS for the next fiscal year.
Globe Life Trading Up 2.5%
Shares of NYSE:GL opened at $139.81 on Wednesday. Globe Life has a 12 month low of $100.27 and a 12 month high of $147.83. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.43. The company's fifty day simple moving average is $140.17 and its 200 day simple moving average is $128.89. The firm has a market cap of $11.32 billion, a price-to-earnings ratio of 11.18 and a beta of 0.55.
Globe Life Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, October 3rd will be given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Friday, October 3rd. Globe Life's dividend payout ratio (DPR) is currently 8.63%.
Insider Activity
In other news, CEO James Matthew Darden sold 33,270 shares of the business's stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $135.59, for a total transaction of $4,511,079.30. Following the transaction, the chief executive officer directly owned 49,842 shares in the company, valued at $6,758,076.78. The trade was a 40.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Frank M. Svoboda sold 12,500 shares of the business's stock in a transaction dated Thursday, July 31st. The stock was sold at an average price of $141.38, for a total transaction of $1,767,250.00. Following the transaction, the chief executive officer owned 32,747 shares in the company, valued at $4,629,770.86. This represents a 27.63% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 84,722 shares of company stock valued at $11,733,793 over the last quarter. 1.97% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the stock. CYBER HORNET ETFs LLC acquired a new position in Globe Life in the 2nd quarter valued at about $28,000. MUFG Securities EMEA plc acquired a new position in Globe Life in the 2nd quarter valued at about $31,000. Headlands Technologies LLC grew its holdings in Globe Life by 893.6% in the 2nd quarter. Headlands Technologies LLC now owns 775 shares of the company's stock valued at $96,000 after buying an additional 697 shares in the last quarter. Quantbot Technologies LP acquired a new position in Globe Life in the 2nd quarter valued at $228,000. Finally, WINTON GROUP Ltd acquired a new position in Globe Life in the 2nd quarter valued at $308,000. Institutional investors and hedge funds own 81.61% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on GL. JPMorgan Chase & Co. lifted their target price on Globe Life from $145.00 to $160.00 and gave the company an "overweight" rating in a research report on Tuesday, July 8th. Truist Financial began coverage on Globe Life in a research report on Tuesday, July 15th. They issued a "buy" rating and a $150.00 target price on the stock. Morgan Stanley set a $179.00 price target on shares of Globe Life and gave the company an "overweight" rating in a research note on Tuesday, October 7th. Wells Fargo & Company lifted their price target on shares of Globe Life from $150.00 to $172.00 and gave the company an "overweight" rating in a research note on Wednesday, October 8th. Finally, Weiss Ratings reiterated a "buy (b-)" rating on shares of Globe Life in a research note on Wednesday, October 8th. Eight investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $152.11.
Get Our Latest Stock Report on GL
About Globe Life
(
Get Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.